ELECSYS HBSAG LL QUANT LLROCHE
TESTINMUNOLÓGICOINVITROPARALADETERMINACIÓNCUANTITATIVA DEL ANTÍGENO DE SUPERFICIE DE LAHEPATITIS B (HBSAG) EN SUERO Y PLASMA HUMANOSCONFIRMADOS COMO POSITIVOS PARA HBSAG. ESTEINMUNOENSAYO DE ELECTROQUIMIOLUMINISCENCIA(ELECTROCHEMILUMINESCENCE IMMUNOASSAY) ”ECLIA”ESTÁPREVISTOPARASUUSOENINMUNOANALIZADORESROCHE.
INVITRO IMMUNOLOGICAL TEST FOR THE QUANTITATIVE DETERMINATION OF HEPATITIS B SURFACE ANTIGEN (HBSAG) IN HUMAN SERUM AND PLASMA CONFIRMED AS POSITIVE FOR HBSAG. THIS ELECTROCHEMILUMINESCENCE IMMUNOASSAY "ECLIA" IS INTENDED FOR USE IN IMMUNOANALYZERSROCHE.
- Risk Class / Clase de Riesgo
- Clase II
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- PRUEBA PARA LADETERMINACIÓN DELANTÍGENO DE SUPERFICIE DELA HEPATITIS B.
- Trade Name (English)
- TEST FOR THE DETERMINATION OF THE SURFACE ANTIGEN OF HEPATITIS B.
- Analysis ID
- 156R2022 SSA
- Registration Date
- March 04, 2022
- Name (Spanish)
- PRODUCTOSROCHE, S.A. DE C.V.
- Name (English)
- PRODUCTOSROCHE, S.A. DE C.V.
Access comprehensive regulatory information for ELECSYS HBSAG LL QUANT LLROCHE (ELECSYS HBSAG LL QUANT LLROCHE) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 156R2022 SSA and manufactured by PRODUCTOSROCHE, S.A. DE C.V.. The device was registered on March 04, 2022.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.